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Natural biomaterials have attracted an increasing interest in the field of tissue-engineered nerve grafts, re-
presenting a possible alternative to autologous nerve transplantation. With the prospect of developing a novel
entubulation strategy for transected nerves with cell-seeded chitosan films, we examined the biocompatibility of
such films in vitro. Different types of rat Schwann cells (SCs)—immortalized, neonatal, and adult—as well as
rat bone-marrow-derived mesenchymal stromal cells (BMSCs) were analyzed with regard to their cell meta-
bolic activity, proliferation profiles, and cell morphology after different time points of mono- and cocultures on
the chitosan films. Overall the results demonstrate a good cytocompatibility of the chitosan substrate. Both cell
types were viable on the biomaterial and showed different metabolic activities and proliferation behavior,
indicating cell-type-specific cell–biomaterial interaction. Moreover, the cell types also displayed their typical
morphology. In cocultures adult SCs used the BMSCs as a feeder layer and no negative interactions between
both cell types were detected. Further, the chitosan films allow neurite outgrowth from dissociated sensory
neurons, which is additionally supported on film preseeded with SC-BMSC cocultures. The presented chitosan
films therefore demonstrate high potential for their use in tissue-engineered nerve grafts.
Introduction
Complete transection injury of a peripheral nerveresults in denervation of target tissue with loss of sen-
sation and motor control. A yearly occurrence of peripheral
nerve injuries of 300,000 cases has been estimated for
Europe.1 Complete nerve transection injuries need surgical
intervention, a treatment that is reported for more than
50,000 cases per year in the United States while the esti-
mated number of unreported cases is much higher.2 The
surgical reconstruction of peripheral nerve continuity has to
be performed in a tension-free coaptation, which is only
possible for small nerve gaps. When extended nerve gaps
are reconstructed by end-to-end suture, tension and drag
force will create reactive fibrosis and impair regrowth of
nerve fibers.3 The clinical gold standard for bridging pe-
ripheral nerve gaps of critical length is the transplantation of
autologous nerve tissue, which is harvested from sensory
nerves (e.g., sural nerve) of the same patient.4 In general,
autologous nerve grafts provide optimal guidance cues for
regenerating nerve fibers, such as peripheral glia cells and
Schwann cells (SCs), which do not only produce regenera-
tion-promoting factors but proliferate and also line their
basal laminae up to the so-called bands of Bu¨ngner, the
guiding tubes within the distal nerve segments.5
Admittedly the use of autologous nerve tissue leads to
loss of sensation at the site of harvest and the functional
outcome after its utilization is described to range from ex-
tremely poor6 to highly satisfying.2 As an alternative to this,
entubulation strategies, using biomaterials, have been per-
formed. However, so far the results have been quite disap-
pointing.
To tackle this, new biomaterials have been developed that
can easily be modified to provide an optimized environment
for peripheral nerve regeneration and qualify as substitutes
for autologous nerve grafts. Chitosan is among the biode-
gradable polymers that demonstrate good properties for
neural tissue engineering.7 It is an attractive material to
produce the outer shell of new nerve grafts because it can
easily be blended with other materials or modified on its
surface to provide guiding and structural cues supporting
axonal regrowth.8
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In this study we investigated the properties of films made
of chitosan in order to produce the outer scaffold of nerve
grafts. Chitosan films can be rolled to form hollow tubes and
the respective surface modifications will allow the fabrication
of tailor-made peripheral nerve grafts. Figure 1 summarizes
these future perspectives for the use of chitosan films.
To tailor the biodegradability of chitosan materials, the
degree of acetylation (DA) can be modified (Fig. 1A, chit-
osan molecule with one acetylation group) by modifying the
number of acetylation groups conjugated to the chitosan.
Further, the films can be seeded with regeneration-
supporting cell types, such as cocultures of SCs and bone-
marrow-derived mesenchymal stromal cells (BMSCs) (Fig.
1B). Both cell types qualify as cellular substitute to tissue-
engineered nerve grafts for different reasons. SCs are cru-
cially involved into the set-up of the pro-regeneration milieu
within the distal nerve segments and the potential of nerve
autotransplantation is mainly attributed to the presence of
this cell type within the grafts.5,9 BMSCs have been de-
scribed as attributable to in vitro transdifferentiation into
SC-like cells,10,11 a feature that would allow to include SC
properties with the benefit of avoiding autologous SC har-
vest. Additionally, despite their putative potential for
transdifferentiation, mesenchymal stromal cells could serve
as living mini-pumps for regeneration-promoting factors.
Indeed the secretome of these cells possesses several growth
factors with strong implications for nervous tissue repair, as
reviewed by Teixeira et al.12 Because both SCs and BMSCs
are potential candidates for peripheral nerve tissue engi-
neering, we tested in this study the cell–biomaterial inter-
actions of both cell types separately as well as in cocultures.
Materials and Methods
Manufacturing of chitosan films
Chitosan films were produced at Medovent GmbH.
Briefly, highly purified chitosan with a DA of 5% (Altakitin
S.A.) was dissolved in 0.75% acetic acid to obtain a 1.5%
solution, filtered, and poured into Petri dishes, followed by
drying at room temperature (RT). The resulting films were
treated with a solution of ammonia in methanol/water,13
followed by intense washing with distilled water, and dry-
ing. Finally, the films were cut into the required size and
sterilized by electron beam. The 5% DA was chosen be-
cause in another study, focusing on in vivo studies of hollow
nonfunctionalized chitosan tubes, this DA demonstrated the
best support for the regenerating peripheral nerve tissue.7
Characterization of chitosan films
Mechanical properties and dimensions. Films were cut
in stripes of *5-mm width. Tensile strength and Young’s
modulus were determined using a mechanical tester (model
Z3; Thu¨mler GmbH) and the software Zpm_v4-5. Film
thickness was determined using a caliper (DURATOOL).
Scanning electron microscopy. To characterize their
surface, chitosan films were observed by scanning electron
microscopy, with a Leica Cambridge S360 (Leica Cam-
bridge). All the samples were previously gold-coated in a
Sputter Jeol JFC 1100 equipment.
Fourier transform infrared spectroscopy. Fourier trans-
form infrared (FTIR) spectrum was collected using Shi-
madzu IRPrestige 21 and samples were prepared as
potassium bromide pellets (KBr; Pike Technologies) at
ambient temperature (25C). The spectrum was collected
using 32 scans with a resolution of 4 cm - 1.
Cell culture
Rat neonatal SCs. Neonatal SCs (neoSCs) were har-
vested from Wistar rat pups (P1–P3). Enzymatic digestion
of isolated sciatic nerves according to Haastert et al.14 was
stopped after 50min with cell culture medium (DMEM,
0.1mM Forskolin, 1% Pen/strep, 2mM L-glutamine, 1mM
sodium pyruvate, and 10% fetal calf serum [FCS]; all from
FIG. 1. Illustration of a strategy for rolling chitosan films to become a hollow nerve guidance channels. (A) By tailoring the
degree of acetylation (DA) when modifying the number of conjugated acetyl groups, the degradation rate of the films can be
adjusted. (B) A chitosan film of adjusted DA further provides a valuable substrate for seeding aligned Schwann cells (SCs) and
bone-marrow-derived mesenchymal stromal cells (BMSCs), both candidate cells for peripheral nerve tissue engineering. Color
images available online at www.liebertpub.com/tea
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PAA Laboratories). The cell suspension was centrifuged for
5min at 235 g. Afterward cells were placed into a poly-L-
lysine (PLL)–coated (final concentration 0.5 ng/mL; Sigma-
Aldrich Chemie GmbH) T25 culture flask (NUNC) and
incubated for 24 h. On the next day half of the medium was
replaced by fresh medium. About 1mM of arabinoside-c
(Sigma-Aldrich Chemie GmbH) was added for 2 days to
suppress overgrowth by fibroblasts. Cells were then purified
via immunopanning15 by magnetic beads Dynabeads (Pan
mouse IgG; Dynal Biotec ASA) coupled to anti-Thy-1 anti-
bodies (own production from hybridoma cell line) and seeded
into a new PLL-coated T25 culture flask. SC purification
procedure was repeated once or twice until > 90% pure neo-
SC cultures were reached.
Adult rat SCs. Adult SCs (aSCs) were harvested from
sciatic nerves of female Wistar rats (200 g, 8–16 weeks). In
vitro predegeneration occurred for 14 days according to a
protocol described previously by Haastert et al.14 Afterward
primary cells were cultured in melanocyte growth medium
(Promocell), 2 mM Forskolin (Calbiochem), FGF-2 (10 ng/
mL; PeproTech), bovine pituitary extract (5 mg/mL BPE-26;
Promocell), 10% FCS, and 1% Pen/strep. After 1 week,
highly enriched aSCs were obtained by using the magnetic-
assisted cell sorting system MACS (Miltenyi Biotec) fol-
lowing the manufacturer’s protocol. Briefly, the unpurified
cultures were detached and washed and the pellet was di-
luted in 998 mL of MACS buffer prior to incubation with
2 mL low-affinity nerve growth factor-receptor antibody
(Millipore; AB 1554) for 15min at 4C. After two washing
steps, 40 mL of microbead-conjugated anti-rabbit IgG was
mixed with cell suspension in MACS buffer and incubated
for further 15min at 4C. After the incubation period, the
cell suspension was flushed through the prepared MACS
columns (Miltenyi; Size M) in the mini MACS magnet and
the unbound fibroblasts were washed out. After removal
from the magnet, bound aSCs were flushed with 2mL
MACS buffer. Highly purified aSCs were then seeded into
poly-ornithin-laminin14 (Sigma-Aldrich, Becton-Dickinson)–
coated T75 culture flasks.
Immortalized SCs. Rat immortalized SCs (iSCs)16 were
cultured in DMEM supplemented with 10% FCS, 1% Pen/
strep, 1% sodium pyruvate, and 1% L-glutamine in non-
coated culture flask.
Rat BMSCs. Isolation and culturing of rat BMSCs from
the femur bone marrow were performed as described be-
fore.17 Isolated cells were cultured in alpha-MEM supple-
mented with 15% fetal bovine serum (FBS; Invitrogen) and
1% antibiotic/antimycotic (Sigma) in sterile T75 and T175
culture flasks until confluence was reached. Cells at pas-
sages 4–6 were detached, seeded on top of the chitosan
films, and cultured with alpha-MEM with 10% FBS and 1%
antibiotic/antimycotic.
Cell seeding on chitosan films
Rat neoSCs (passage 6–8) and iSCs were seeded into 24-
well plates with a density of 1 · 104 cells/well (iSCs) or
3.5 · 104 cells/well (neoSCs) on PLL (Sigma)–coated wells
or noncoated chitosan films clamped into cell crowns
(Scaffdex) in a volume of 400 mL of cell-specific culture
medium. After 1 h of incubation, more medium was added
to a total volume of 900mL/well. The medium was changed
twice a week and cells were cultivated over 5 days in vitro
(DIV) for iSCs and 7 DIV for neoSCs. Rat aSCs (passage 3–
6) and rat BMSCs (passage 4–6) were seeded on coated
coverslips into 24-well plates with a density of either
3.5 · 104 cells/well (aSCs, poly-ornithin laminin coating) or
2 · 104 cells/well (BMSCs, poly-D-lysine; Sigma) or on
noncoated chitosan films clamped into cell crowns (Scaff-
dex) in a volume of 75 mL of cell-specific culture medium.
After 1 h of incubation, more medium was added to a total
volume of 800mL/well. Medium was changed twice a week
and cells were cultivated until 7 DIV.
Metabolic activity evaluation by WST-1
and MTS assays
WST-1 test or MTS assay was chosen to evaluate meta-
bolic activity of different cell types seeded on chitosan
films. The respective assay was chosen with regard to the
best experiences from previous studies with either test for
the cell types to be analyzed.
For the iSC and neoSC experiments, cell metabolic
activity was compared in the WST-1 test (Cell Prolifera-
tion Reagent; Roche). WST-1 {4-[3-(4-Iodophenyl)-2(4-
nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate} is
reduced by dehydrogenase enzymes to a dark red compound
in cells with metabolic activity, and is particularly suitable
for the cell types used. After cultivation periods—1, 3, and 5
DIV for iSCs or 3, 5, and 7 DIV for neoSCs—cell crowns
were transferred to new wells of the same plate and cell-
specific culture medium containing the WST-1 compound
was added (1:10, 400 mL/controls and 900mL/cell crown).
Cells were incubated for *3.5 h at 37C in humidified at-
mosphere with 8% (v/v) CO2. Afterward triplicates of
100mL from each sample were transferred to 96-well plates
and the optical density (OD) was measured at 450 nm using
a multiwell plate reader (ELx800 BioTek Instruments). The
test was performed in n = 3 experiments with each two sister
cultures per condition.
For aSCs and BMSCs, cell metabolic activity was com-
pared in the MTS test (Cell Titer 96AQueous Cell Pro-
liferation Assay; Promega). The MTS compound [3-(4,5
dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2 (4
sulfophenyl) 2H-tetrazolium inner salt] is reduced by de-
hydrogenase enzymes to a brownish formazan product in
cells with metabolic activity. After 2 and 7 DIV, coverslips
and cell crowns were transferred to new wells of the same
plate and serum-free culture medium (aSCs) or DMEM
(BMSCs) containing the MTS compound was added (5:1,
350mL/controls and 850mL/cell crown). Cells were incu-
bated for *3 h at 37C in humidified atmosphere with 5%
(v/v) CO2. Afterward triplicates of 100mL from each sample
were taken to 96-well plates and the OD was measured at
490 nm using a multiwell plate reader (Biorad Model 680).
This test was performed in n= 3 experiments with each three
sister cultures per condition.
Cell proliferation
The cell proliferation rate of aSCs and BMSCs was de-
termined with the BrdU colorimetric assay (Roche) that is
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based on the detection of BrdU (thymidine analogue) in-
corporation into genomic DNA of proliferating cells by
binding of anti-BrdU (a-BrdU) antibody. The procedure was
assessed according to the manufacturing protocol. Therefore
at 2 and 7 DIV, cell-seeded coverslips and chitosan films in
cell crowns were incubated with 10mM BrdU diluted in cell-
specific culture medium for 24 h, afterward fixed in Fix-
Denat solution and then incubated for *1.5 h in a solution
containing a-BrdU-POD. After washing (3 · in washing
buffer) and 15-min incubation with TMB solution, tripli-
cates of 100mL of each condition were transferred to 96-
well plates and the OD was measured in an ELISA plate
reader (BioRad Model 680) at 405/490 nm. Cell prolifera-
tion was determined in n= 3 experiments with each three
sister cultures per condition.
Coculture experiments of aSCs with rat BMSCs
To evaluate stimulatory or inhibitory effects on the
growing characteristics and the proliferation behavior of
cocultured aSCs (1.75 · 104 cells/well) and BMSCs (1 · 104
cells/well), a direct coculture on chitosan films and poly-
D-lysine-coated glass coverslips was performed. Cells were
grown in aSC medium over 2 and 7 DIV in n= 3 experi-
ments with each three sister cultures per condition.
Preparation and cultivation of primary dissociated
rat dorsal root ganglia
Dorsal root ganglia (DRGs) were dissected from neonatal
Wistar rats (P1–P3) and collected in HBSS medium (Hank’s
balanced salt solution without magnesium and calcium;
PAA Laboratories). After isolation, ganglia were incubated
in dissociation solution (HBSS, trypsin-0.125% [Gibco], and
0.1% DNase [0.5% stock; Roche Diagnostics]) for 20min at
37C. Then, collagenase IV (160U/mg; PAA Laboratories)
was added for another 25min. Digestion of DRGs was stop-
ped by adding N2 medium with 3% FCS (DMEM-F12 [PAA
Laboratories], 1· N2-supplement [100· ; Gibco], 0.25% bo-
vine serum albumin [BSA, fraction V, 25% stock; Sigma-
Aldrich Chemie GmbH], 2mM L-glutamine, 1% Pen/strep,
and 1mM sodium pyruvate [PAA Laboratories]). Ganglia
were then mechanically dissociated in a homogenous sus-
pension using a fire-polished glass Pasteur pipette. After
centrifugation, 10 · 104 DRG cells were seeded on top of
poly-ornithin-laminin-coated coverslips (control condition)
or plain or cell-seeded chitosan films, respectively.
After 24 h, control condition cultures were separated into
nontreated and 50 ng/mL free recombinant nerve growth
factor (NGF, Invitrogen)–supplemented sister cultures. All
other cultures were kept without NGF supplement. Cells
were grown over 2 and 7 DIV in sister cultures.
Immunocytochemistry and phalloidin/DAPI staining
To evaluate cell morphologies immunocytochemistry was
performed. Therefore, coverslips or chitosan films were
gently washed with phosphate-buffered saline (PBS) and
fixed for 30min with 4% paraformaldehyde (Merck). Rat
aSCs were incubated overnight (4C) with SC-specific a-
S100 antibody (polyclonal, 1:200; Dako) in PBS/0.3% Tri-
ton X-100/5% BSA (PAA) solution. After washing with
PBS, an incubation with Cy2-labeled goat a-rabbit sec-
ondary antibody (1:2000; Invitrogen) for *1.5 h at RT
followed. To identify BMSCs, their actin filaments were
stained for 30min with phalloidin-tritc fluorescence stain
(1:500; Sigma). All cell nuclei were counterstained with
DAPI (1:1000; Invitrogen D1306). After final washing,
coverslips and chitosan films were mounted on glass slides
with Shandon-Immu-Mount (Thermo Fisher).
To distinguish between the cell populations in coculture
experiments, cells were fixed and stained by Phalloidin/
DAPI for 30min and then incubated overnight with the a-
S100 antibodies followed by their detection with Cy2-
labeled goat a-rabbit secondary antibody. Microscopical
analyses were carried out under the fluorescence micro-
scope (BX61; Olympus). For quantification, six images per
condition were captured at · 20 magnification using Cell
P (Olympus) and Image J software (Wayne Rasband).
For detection of neurite outgrowth, dissociated DRG
cultures on coated coverslips and chitosan films were wa-
shed and fixed on 2 and 7 DIV as described previously for
aSCs. Blocking of unspecific antibody binding was induced
by incubation with PBS/0.3 Triton X-100 containing 3%
normal goat serum (NGS, Gibco) for 1 h at RT. Dissociated
DRGs were incubated overnight (4C) with neuron-specific
a-b-III-tubulin antibody (monoclonal, 1:500; Upstate Bio-
technology) in PBS/0.3% Triton X-100 containing 1% NGS.
After washing with PBS, incubation with Alexa 647-labeled
goat a-mouse secondary antibody (1:400; Invitrogen) for
*1.5 h (RT) followed. Cell nuclei were counterstained with
DAPI (1:1000; Sigma-Aldrich). After final washing, cov-
erslips and chitosan films were mounted and coverslipped as
described previously.
Statistics
Statistical analysis was performed using GraphPad Prism
software version 5.0.3.0 for windows (GraphPad Software,
Inc.). Data represent mean – standard error of the mean
(SEM). Statistical differences were assessed by two-way
ANOVA followed by Bonferroni post hoc test for multiple
comparisons. p-Values with p < 0.05 were regarded as
statistically significant.
Results
The mechanical properties of the chitosan films were
determined as listed in Table 1. Thickness, tensile strength,
and Young’s modulus were not significantly affected by
beta-sterilization.
The scanning electron microscopic images (Fig. 2A)
acquired revealed a flat and smooth surface of the chitosan
films with minor defects. Additionally, from the FTIR
analysis (Fig. 2B), a typical spectrum of chitosan, con-
firming its saccharide structure,18 was obtained; namely,
A band at 3441 cm - 1 corresponds to the combined peaks
of the NH2 and OH group stretching vibration of chitosan.
The bands at 1641 and 1380 cm - 1 correspond to the
C =O and C-O stretching of amide group.
A band at wavenumber 1598 cm - 1 is due to the N-H
deformation of amino groups.
Wavenumbers 1156 and 1025 cm - 1 correspond to the
symmetric stretching of the C-O-C.
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Metabolic activity of different primary and iSCs
increased over culture periods on chitosan films
To investigate the initial cytocompatibility properties of
chitosan films, direct contact assays with rat iSCs and
neoSCs were performed and compared with control cultures
on PLL coating. The interaction of the cells with the sub-
strates was evaluated after different culture periods by
measuring their metabolic activity in the WST-1 assay. For
both cell types metabolic activity was, at all time points
investigated, significantly higher in control cultures than on
noncoated chitosan films. However, cells cultured on chit-
osan films were viable and showed a significant increase in
their metabolic activity over time as did the control cultures
(Fig. 3A, B).
aSCs and BMSCs show differences in metabolic
activity and proliferation behavior on chitosan
film substrates
For both cell types metabolic activity was, at all time
points investigated, significantly higher in control cultures
than on noncoated chitosan films and it showed an increase
over time (Fig. 3C, D). In contrast to what was seen with
iSCs and neoSCs, rat aSCs showed a nonsignificant decrease
of their metabolic activity (MTS assay) between 2 and 7
DIV (Fig. 3C). Rat BMSCs however demonstrated the op-
posite, an increasing metabolic activity from 2 to 7 DIV
(Fig. 3D).
Interestingly, also the proliferation behavior of rat aSCs
and BMSCs showed opposite characteristics on chitosan
film substrates (Fig. 3E, F). During the measured period of
24 h from 2 to 3 DIV nonsignificantly less aSCs were pro-
liferating than during 24 h between 7 and 8 DIV. In the latter
time period the proliferation rate was significantly higher in
chitosan film cultures than in controls (Fig. 3E). In contrast,
nonsignificantly higher proliferation rates were detected in
early chitosan film BMSC cultures (2–3 DIV) than in older
ones (7–8 DIV) with no significant difference to control
cultures (Fig. 3F).
The viability of aSCs and BMSCs on chitosan film sub-
strates was confirmed by immunofluorescence (Fig. 4),
showing aSCs with their typical spindle-shaped morphol-
ogy, while BMSCs appeared on 2 DIV with a contracted
morphology that changed to their regular more flattened
morphology only at 7 DIV.
Relative cell numbers of BMSCs and aSCs were stable
when cocultured on chitosan film substrates
A direct coculture of aSCs and BMSCs on chitosan films
and control substrates revealed in immunofluorescence that
aSCs grew on top of the BMSCs (Fig. 5A, B). The topog-
raphy of cell growth indicates that BMSCs served as a feeder
layer for aSCs in the coculture system. The number of viable
cells was determined in order to calculate the relative pro-
portion of the two cell populations when cultured on the
Table 1. Results of the Mechanical Property Testing of Nonsterile Chitosan Films








W3R3-1205/01 Yes 0.04 – 0.011 5.6 – 2.2 0.47 – 0.09
W3R3-1205/01 No 0.035– 0.005 6.8 – 1.69 0.41 – 0.15
Data are presented as mean – standard deviation.
FIG. 2. Characterization of chitosan films. Scanning electron microscopy (A) analysis revealed a relative smooth surface
while with Fourier transform infrared spectroscopy spectra (B) a typical spectrum of chitosan was obtained.
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substrates (Fig. 5C). While the relative number of cultured
BMSCs increased significantly on control substrates from
*61% at 2 DIV to *75%, the relative number of aSCs
decreased significantly from *40% to *25%. On chitosan
film substrates the change in relative cell numbers is nego-
tiable for both cell types and similar to control conditions at 7
DIV. The relative proportion in early cultures on chitosan
films is however significantly different to cultures on control
substrates, with higher relative numbers of BMSCs and less
relative numbers of aSCs growing on the chitosan films.
FIG. 3. Cell metabolic activity of different cell types on chitosan films. (A)Rat immortalized SCs (iSCs; 1· 104 cells/well) and
(B) rat neonatal SCs (neoSCs; 3.5· 104 cells/well) were cultured on different chitosan films (5% DA) for up to 7 days in vitro
(DIV). Themetabolic activitymeasured in theWST-1 assay (optical density [OD] 450 nm) showed an increase after 3DIV for both
iSCs and neoSCs. Control condition cultures always displayed significantly higher metabolic activities than experimental cultures.
Bars represent mean– standard error of themean (SEM) (n= 3 experiments, ***p< 0.001). Cellmetabolic activity of rat adult SCs
(aSCs) and rat BMSCs cultured on chitosan films. (C) aSCs and (D) BMSCs were cultured on chitosan films for 2 and 7 DIV.
Metabolic activity showed a nonsignificant decrease after 7DIV in aSCswhile inBMSCs it is increased. Control condition cultures
always displayed significantly highermetabolic activities than experimental cultures. Bars represent mean–SEM (n= 3, two-way
ANOVAAAAp< 0.0001,AAp< 0.001,Ap< 0.05). Proliferation rates of rat aSCs and BMSCswhen cultured on chitosan films for
different periods. (E) aSCs and (F) BMSCs were cultured for 2 and 7 DIV. Proliferation rate was determined for a 24-h window
preceding fixation on 2 and 7 DIV. aSCs showed a nonsignificant increase in proliferation with prolonged culture, while BMSCs
showed a nonsignificant decrease that was not significant. Bars represent mean–SEM (n= 3; two-way ANOVA *p< 0.05).
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Axonal outgrowth on chitosan films is increased
after preseeding with aSC-BMSC cocultures
To proof the principle that cocultures of aSCs and
BMSCs could support neurite outgrowth through chitosan-
film-based nerve grafts, dissociated DRG cells were cultured
on poly-ornithin-laminin-coated controls or on top of either
plain films or those seeded with aSC-BMSC cocultures 2
and 7 DIV, respectively. Under control conditions less
neurite outgrowth was detected (Fig. 6A, B) compared with
FIG. 4. Immuno-
fluorescence of rat aSCs and
BMSCs on chitosan films.
aSCs (green, a-S100) were
viable and showed their
typical spindle-shaped mor-
phology on 2 DIV (A) and 7
DIV (B). BMSCs (red, F-
actin filaments) were viable
but showed a contracted
morphology on 2 DIV (C)
and presented their typical
fibroblast-like morphology
only on 7 DIV (D). All nuclei
counterstained with DAPI.
Scale bar= 100mm. Color
images available online at
www.liebertpub.com/tea
FIG. 5. Quantification of
relative cell numbers (%) of
BMSCs and aSCs in direct
coculture on chitosan films
versus control substrates.
Significant differences be-
tween 2 and 7 DIV were ob-
served on control substrates
for both BMSCs and aSCs,
but in opposite direction. No
significant differences in rel-
ative cell numbers were de-
tected for either cell type
over time in cocultures on
chitosan films (C). Bars
shown as mean – SEM; n = 3.
Representative photomicro-
graphs of BMSCs stained for
F-actin filaments (phalloidin
in red) and a-S100-positive
aSCs (green) on 2 DIV (A)
and 7 DIV (B). Scale bar=
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control culture supplemented with NGF (Fig. 6C, D). On
plain chitosan films, without NGF supplementation, some
clustering of the dissociated DRG cells was visible (Fig. 6E,
F) but neurite outgrowth was supported to a higher extend
than under control conditions plus NGF. The neurite out-
growth was however best supported when dissociated DRG
cells were seeded on aSC-BMSC-coculture-preseeded chit-
osan films (no NGF added, Fig. 6G, H).
Discussion
This study was performed with the prospect of a novel
entubulation strategy in which chitosan films could be see-
ded with supportive cells and used as a composite guiding
conduit for peripheral nerve repair. We characterized chit-
osan films with a DA of *5% in terms of mechanical
properties and surface topography. The degradation rates of
chitosan films of different DA were determined in another
study before and chitosan films with a DA of *5% dem-
onstrated a mass loss < 10% over 28 days in presence of
lysozyme in vitro.18 We also evaluated the biocompatibility
of the chitosan films with different cell types.
Scanning electron microscopic analysis of the chitosan
films revealed a flat and smooth surface. It is known that
surface properties of biomaterials, such as their chemical
structure and topography, are essential for adhesion and
FIG. 6. Immuno-
fluorescence of rat primary
dissociated dorsal root gan-
glia (DRGs) axonal out-
growth. Dissociated DRG
cells (red, a-b-III-tubulin) in
absence of nerve growth
factor (NGF) (control 1) on 2
DIV (A) and a slightly in-
creased neurite outgrowth on
7 DIV (B). In presence of
NGF (control 2) on 2 DIV
(C) with an increased neurite
outgrowth on 7 DIV (D). On
plain chitosan films cluster
formation with increased
neurite outgrowth occurred
till 2 DIV (E) and was further
increased till 7 DIV (F). (G,
H) On chitosan films pre-
seeded with cocultures of
aSCs and BMSCs, axonal
outgrowth and network for-
mation was further intensi-
fied over time. Blue: nuclear
staining (DAPI); scale bars =
200mm. Color images
available online at www
.liebertpub.com/tea
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proliferation of cells19 and in that context important for
acceptance or rejection of those materials in vivo. The
monitored surface as such showed no negative properties
that would limit the use of chitosan films in peripheral nerve
repair. Biocompatibility of chitosan materials in terms of
better cell adhesion and proliferation can be modified by
deacetylation of the raw material.18 Cell lines are widely
used for in vitro cytotoxicity assessments but the transmis-
sion to a clinical situation is restricted to data obtained with
primary target cells or data obtained in vivo. To gain a more
comprehensive view on the chitosan film properties, beside
iSCs, primary neoSCs and aSCs, with a special focus on the
aSCs, were analyzed. SCs are the main players in the sce-
nario of peripheral nerve regeneration. In a clinical setting
of peripheral nerve reconstruction aSCs are crucially in-
volved when focusing on the mean age of the population
with peripheral nerve injuries.20,21 As a second cell type
with regeneration-promoting properties,22–24 BMSCs were
analyzed.
All cell populations were grown on chitosan films with
5% DA that has been considered to be optimal for glial cells,
given that previous studies demonstrated adverse effects for
different cell types when higher DAs were used.18,25–27 The
results of the direct-contact assays clearly demonstrated that
our chitosan films provide a suitable biomaterial with good
cell adhesion and proliferation properties and allow axonal
outgrowth.
iSCs and primary neoSCs as well as BMSCs demon-
strated an increased metabolic activity over culture time on
chitosan films (Fig. 3A, B, and D). This is in agreement with
the metabolic activity changes found for other cell types
from different origin when seeded on chitosan with DA
< 10%.18,26,28,29 In contrast, aSCs cultured on the chitosan
films showed a nonsignificant decrease in their metabolic
activity on 7 DIV (Fig. 3C). These cell-type-specific dif-
ferences are of particular importance with respect to the
impact of aSCs on the peripheral nerve regeneration pro-
cess. Although other authors conclude from a reduced
metabolic activity to a reduced cell viability,25,28 we did not
see impaired cell viability when analyzing our cultures in
immunofluorescence. The significantly higher metabolic
activity measured under control conditions has to be at-
tributed to the highly optimized culture conditions induced
by the cell-specific coating used. From the chitosan film
cultures, however, we assume that aSCs adapt faster to the
biomaterial with a reduced reaction to the chitosan and a
subsequently reduced metabolism than iSCs or neoSCs or
BMSCs. Also, the significant increase of proliferating aSCs
until 7 DIV (Fig. 3E) argues against a reduced viability of
this cell type on chitosan films. With regard to cell prolif-
eration, BMSCs again demonstrated an opposite behavior to
aSCs. Proliferation rates at 2 DIV were lower in aSCs than
in BMSCs and at 7 DIV the opposite was detected. These
observations can be explained by a reduction of cell-free
material surface needed for further cell expansion due to
increased cell numbers until 7 DIV for BMSCs.30 aSCs
showed a slower growth and could therefore still increase
their proliferation rates at 7 DIV. Despite of cell-type-
specific differences regarding metabolic activity and pro-
liferation behavior between aSCs and BMSCs, both cell
types were viable and adhered well to the substrate. These
observations were also confirmed by immunofluorescence
showing typical spindle-shaped aSCs on 2 and 7 DIV
(Fig. 4A, B) while BMSCs appeared initially contracted but
with prolonged culture they changed to their regular mor-
phology (Fig. 4C, D). The latter is another evidence for the
conclusion that BMSCs need more time to adapt to the
chitosan surface than aSCs.
Recent investigations demonstrated that transplanted
mesenchymal stromal cells are therapeutically efficient in
models of different neurological disorders, including pe-
ripheral nerve regeneration, either by differentiation into an
SC-like phenotype or by using them as a source of growth
factors.31–33 To study the possible synergistic or inhibitory
effects of aSCs and BMSCs, both cell types were directly
cocultured on chitosan films (Fig. 5). Similar to the results
obtained from monocultures both cell types were viable and
adhered to the chitosan substrate. It is noteworthy that aSCs
grew on top of the BMSCs, using them as a feeder layer. In
prospect of composite nerve entubulation strategies, the
demonstrated growth behavior would allow the aSCs to be
in direct contact with regrowing axons while receiving
trophic support from the underlying BMSCs. To detect cell
type interactions, relative cell numbers of both cell popu-
lations were determined under control conditions and on
chitosan films. While under control conditions, the relative
cell number of BMSCs increased on 7 DIV and that of aSCs
decreased; on the chitosan films, the relative cell number for
both aSCs and BMSCs remained stable. This indicates that
aSCs and BMSCs did not negatively affect each other.
Further, axonal outgrowth from dissociated DRG cells cul-
tured on chitosan films was evidently stronger than under
positive control conditions (poly-ornithin-laminin-coated
glass coverslips and NGF supplementation, Fig. 6A–F).
Chitosan films preseeded with aSC-BMSC cocultures fur-
ther proved to be even more supportive of axonal outgrowth
(Fig. 6G, H).
In future studies, the coculture of aSCs and BMSCs needs
to be further analyzed for the effects of the BMSC secre-
tome on aSC behavior. Therefore higher cell densities and
prolonged culture periods need to be established.
We demonstrate here as a proof-of-principle that chitosan
films of 5% DA are a suitable biomaterial that supports
viability and adhesion of glial cells, specifically SCs and
BMSCs, and that both cell types can be cocultured in order
to cotransplant them for peripheral nerve reconstruction.
This conclusion is supported by the finding that massive
neurite outgrowth from sensory neurons is induced on chit-
osan films preseeded with aSC-BMSC cocultures. A com-
posite entubulation strategy including chitosan films seeded
with autologous SCs and BMSCs could not only be sup-
portive for axonal regrowth but also for the growth and
function of resident SCs in the adjacent nerve ends. These
cells could also be positively influenced by the secretome of
the transplanted BMSCs.
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